HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Martine Wallon Selected Research

Congenital Toxoplasmosis

10/2020Performance of a Toxo IgM prototype assay for the diagnosis of maternal and congenital Toxoplasma infections.
9/2020Toxoplasmosis screening during pregnancy in France: Opinion of an expert panel for the CNGOF.
1/2016Treatment of Congenital Toxoplasmosis: Safety of the Sulfadoxine-Pyrimethamine Combination in Children Based on a Method of Causality Assessment.
12/2015Place of Interferon-γ Assay for Diagnosis of Congenital Toxoplasmosis.
4/2015Use of IgG in oral fluid to monitor infants with suspected congenital toxoplasmosis.
8/2012Comparison of mother and child antibodies that target high-molecular-mass Toxoplasma gondii antigens by immunoblotting improves neonatal diagnosis of congenital toxoplasmosis.
1/2010Diagnosis of congenital toxoplasmosis by using a whole-blood gamma interferon release assay.
6/2008Genetic and epigenetic factors at COL2A1 and ABCA4 influence clinical outcome in congenital toxoplasmosis.
1/2008Risk factors for retinochoroiditis during the first 2 years of life in infants with treated congenital toxoplasmosis.
1/2007Screening for congenital toxoplasmosis: accuracy of immunoglobulin M and immunoglobulin A tests after birth.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Martine Wallon Research Topics

Disease

13Infections
10/2020 - 03/2004
12Congenital Toxoplasmosis
10/2020 - 06/2004
3Toxoplasmosis
10/2016 - 03/2006
2Mycoses (Diseases, Fungus)
10/2021 - 06/2020
2Persistent Infection
10/2020 - 11/2004
2Ocular Toxoplasmosis
10/2018 - 03/2006
1Alveolar echinococcosis
09/2020
1Aspergillosis
07/2020
1Endophthalmitis (Ophthalmia)
07/2020
1Candidiasis (Moniliasis)
06/2020
1Rubella (German Measles)
05/2019
1Anemia
01/2016
1Diarrhea
01/2016
1Eosinophilia
01/2016
1Neutropenia
01/2016
1Vomiting
01/2016
1Echinococcosis (Hydatid Cysts)
08/2014
1Chorioretinitis
01/2013
1Brain Diseases (Brain Disorder)
06/2008

Drug/Important Bio-Agent (IBA)

7Immunoglobulin G (IgG)IBA
10/2020 - 11/2004
5Immunoglobulin M (IgM)IBA
10/2020 - 01/2007
4Pyrimethamine (Daraprim)FDA Link
09/2020 - 10/2004
4AntigensIBA
12/2015 - 11/2004
3Immunoglobulin A (IgA)IBA
10/2018 - 01/2007
2Biological ProductsIBA
09/2020 - 07/2020
2Retinaldehyde (Retinal)IBA
09/2020 - 06/2004
2SpiramycinIBA
09/2020 - 01/2013
2AntibodiesIBA
08/2012 - 11/2004
1MannansIBA
10/2021
1Immunoglobulins (Immunoglobulin)IBA
10/2020
1Sulfadiazine (Sulphadiazine)FDA Link
09/2020
1Voriconazole (Vfend)FDA LinkGeneric
07/2020
1galactomannanIBA
07/2020
1ethyleneIBA
06/2020
1AcidsIBA
06/2020
1DiaminesIBA
06/2020
1Edetic Acid (EDTA)FDA Link
06/2020
1GoldIBA
05/2019
1pyrimethamine drug combination fanasil (Fansidar)FDA Link
01/2016
1Pharmaceutical PreparationsIBA
01/2016
1InterferonsIBA
12/2015
1Dihydrotachysterol (AT 10)IBA
01/2013
1Interferon-gamma (Interferon, gamma)IBA
01/2010
1Collagen Type II (Type II Collagen)IBA
06/2008
1Member 4 Subfamily A ATP Binding Cassette TransporterIBA
06/2008
1SulfonamidesIBA
01/2008
1CytokinesIBA
03/2006
1Interleukin-10 (Interleukin 10)IBA
03/2006
1ImmunosorbentsIBA
11/2004
1EnzymesIBA
11/2004
1Sulfadoxine (Sulformethoxine)FDA Link
10/2004
1DNA (Deoxyribonucleic Acid)IBA
03/2004

Therapy/Procedure

1Lung Transplantation
09/2020
1Vitrectomy
07/2020
1Pancreas Transplantation
06/2018
1Induced Labor
05/2015
1Punctures
08/2014
1Cystectomy
08/2014
1Therapeutics
06/2004